Stockreport

Galectin stock lifts 15% premarket on early cancer combination trial results [MarketWatch]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF Galectin stock lifts 15% premarket on early cancer combination trial results Galectin Therapeutics Inc. GALT, +6.38% shares surged 15% in Thursday premarket trade aft [Read more]